Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S., Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell’Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in International journal of hematology (01.02.2022)
Published in International journal of hematology (01.02.2022)
Get full text
Journal Article
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease : Potential for a prognostic factor
WEIHRAUCH, Martin R, MANZKE, Oliver, BEYER, Marc, HAVERKAMP, Heinz, DIEHL, Volker, BOHLEN, Heribert, WOLF, Juergen, SCHULTZE, Joachim L
Published in Cancer research (Chicago, Ill.) (01.07.2005)
Published in Cancer research (Chicago, Ill.) (01.07.2005)
Get full text
Journal Article
Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes
Kolossov, E, Lu, Z, Drobinskaya, I, Gassanov, N, Duan, Y, Sauer, H, Manzke, O, Bloch, W, Bohlen, H, Hescheler, J, Fleischmann, B. K
Published in The FASEB journal (01.04.2005)
Published in The FASEB journal (01.04.2005)
Get more information
Journal Article
항-CD19 병용 요법
SEGUY FRANCIS, FINGERLE ROWSON GUNTER, MANZKE OLIVER, BRUGGER WOLFRAM
Year of Publication 13.09.2023
Get full text
Year of Publication 13.09.2023
Patent
A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL)
Sehn, Laurie Helen, Scholz, Christian W, Luminari, Stefano, Salar, Antonio, Wahlin, Bjorn E., Gopal, Ajay K., Bonnet, Christophe Marc, Paneesha, Shankara, Manzke, Oliver, Seguy, Francis, Li, Di, Hübel, Kai
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Get full text
Journal Article
Conference Proceeding
Phase II study of durvalumab (anti-PD-L1 antibody) in combination with R-CHOP or lenalidomide plus R-CHOP in previously untreated, high-risk diffuse large B-cell lymphoma
Nowakowski, Grzegorz S., Kalakonda, Nagesh, Truemper, Lorenz, Everaus, Hele, Fustier, Pierre, Jaeger, Jonathan, Manzke, Oliver, Jäger, Ulrich
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Poster: IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)
Sehn, Laurie H., Scholz, Christian W., Luminari, Stefano, Salar, Antonio, Wahlin, Björn E., Gopal, Ajay K., Bonnet, Christophe, Trneny, Marek, Paneesha, Shankara, Manzke, Oliver, Seguy, Francis, Li, Di, Hübel, Kai
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)
Sehn, Laurie H., Scholz, Christian W., Luminari, Stefano, Salar, Antonio, Wahlin, Björn E., Gopal, Ajay K., Bonnet, Christophe, Trneny, Marek, Paneesha, Shankara, Manzke, Oliver, Seguy, Francis, Li, Di, Hübel, Kai
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R 2 -CHOP in subjects with previously untreated, high-risk DLBCL
Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas Stauffer, Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trumper, Lorenz H., Haioun, Corinne, Everaus, Hele, Kalakonda, Nagesh, Knoble, Jeanna, Brown, Peter, Joergensen, Judit Meszaros, Cunningham, David, Domper, Neus, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Nowakowski, Grzegorz S, Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S, Patel, Krish, Jäger, Ulrich, Manges, Robert F, Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell'Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in International journal of hematology (01.02.2022)
Get full text
Published in International journal of hematology (01.02.2022)
Journal Article
A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL
Czuczman, Myron S., Davies, Andrew, Linton, Kim M, Wagner-Johnston, Nina, Gascoyne, Randy D., Eberhard, David A., Salles, Gilles, Witzig, Thomas E., Zinzani, Pier Luigi, Wright, George W., Staudt, Louis M., Repici, Jacqueline, Song, Dale, Manzke, Oliver, Lewis, Ian D
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Vaccination of multiple myeloma patients with idiotype‐pulsed dendritic cells: immunological and clinical aspects
Titzer, Sandra, Christensen, Olaf, Manzke, Oliver, Tesch, Hans, Wolf, Jürgen, Emmerich, Berthold, Carsten, Cornelia, Diehl, Volker, Bohlen, Heribert
Published in British journal of haematology (01.03.2000)
Published in British journal of haematology (01.03.2000)
Get full text
Journal Article
Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma
Borchmann, Peter, Schnell, Roland, Fuss, Irene, Manzke, Oliver, Davis, Thomas, Lewis, Lionel D., Behnke, Detlev, Wickenhauser, Claudia, Schiller, Petra, Diehl, Volker, Engert, Andreas
Published in Blood (01.11.2002)
Published in Blood (01.11.2002)
Get full text
Journal Article
ANTI-CD19 COMBINATION THERAPY
MANZKE, Oliver, FINGERLE-ROWSON, Günter, BRUGGER, Wolfram, SEGUY, Francis
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent
Locoregional treatment of low‐grade B‐cell lymphoma with CD3×CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses
Manzke, Oliver, Tesch, Hans, Lorenzen, Johann, Diehl, Volker, Bohlen, Heribert
Published in International journal of cancer (15.02.2001)
Published in International journal of cancer (15.02.2001)
Get full text
Journal Article
ANTI-CD19 COMBINATION THERAPY
MANZKE, Oliver, FINGERLE-ROWSON, Günter, BRUGGER, Wolfram, SEGUY, Francis
Year of Publication 11.10.2023
Get full text
Year of Publication 11.10.2023
Patent